Manufacturer record
Biologics Inc: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Biologics Inc (Himachal Pradesh) were declared Not of Standard Quality between December 2022 and February 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 122257, Ofloxacin and Ornidazole Tablets IP (Normal -OZ TABLETS) (exp Nov 2024). RDTL Chandigarh (state lab) found it not of standard quality: Dissolution of Ofloxacin and Ornidazole. Listed in the February 2024 alert.
Records by type
2 records linked to Biologics Inc in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ofloxacin and Ornidazole Tablets IP (Normal -OZ TABLETS) | Batch 122257Mfg Dec 2022 · Exp Nov 2024 | Dissolution of Ofloxacin and OrnidazoleDissolution | RDTL ChandigarhState lab | Feb 2024 |
| Telmisartan and Hydrochlorothiazide Tablets IP (SARTAN-H TABLETS) | Batch 12259Mfg Jan 2022 · Exp Dec 2023 | Dissolution of TelmisartanDissolution | RDTL ChandigarhState lab | Dec 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.